Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00094744 · ClinicalTrials.gov registry record · Phase 3
Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia
A Phase 3 study of Amblyopia, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 175
- Enrollment target
- 1
- Study location
NCT00094744: Completed Phase 3 study of Amblyopia, sponsored by Jaeb Center for Health Research.
NCT00094744 is a Phase 3 study of Amblyopia that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 175 participants, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00094744, a Phase 3 study of Amblyopia, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this study are: * To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with full-time patching (all or all but one waking hour) for severe amblyopia. * To develop more precise estimates than currently available for the visual acuity improvement that occurs during treatment of amblyopia with patching. * To identify factors that may be associated with successful treatment of amblyopia with patching.
Conditions Studied
Interventions
- DEVICE Eye patch
Study Locations (1)
Maryland
- Wilmer Eye Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2001-05 |
| Est. Completion | 2003-09 |
| Phase | Phase 3 |
What the finished NCT00094744 record still lists
NCT00094744 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 1 intervention - of which Eye patch is the first listed.
NCT00094744 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00094744 about?
NCT00094744 is a clinical study titled "Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia". The goals of this study are: * To determine whether the visual acuity improvement obtained with part-time (6 hours) patching is equivalent to the visual acuity improvement obtained with full-time patching (all or all but one waking hour) for severe amblyopia. * To develop more precise estimates tha...
What is the current status of trial NCT00094744?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 175 participants. The study started on 2001-05. Estimated completion is 2003-09.
What conditions does trial NCT00094744 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT00094744?
The interventions under investigation include: Eye patch (DEVICE).
Who is sponsoring clinical trial NCT00094744?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00094744 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00094744's enrollment target sits among peer trials
175 10th of 24 higher than 15 of 24 other Amblyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RECRUITING · Phase 3
-
Amblyopia (Lazy Eye) Treatment Study
COMPLETED · Phase 3
-
Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children
COMPLETED · Phase 3
-
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia